Fox Chase Cancer Center Scientist to Receive John Scott Award
PHILADELPHIA (November 10, 1998) -- For his outstanding contributions to the advancement of international science and medicine, Baruch S. Blumberg, M.D., Ph.D., a Fox Chase Cancer Center Distinguished Scientist, will be presented with the John Scott Award Friday, November 20, at 5 p.m. at the Chemical Heritage Foundation in Philadelphia.
The Award is given to deserving men and women whose inventions have furthered the happiness and welfare of mankind. It was established in the early 1800s by Edinburgh druggist John Scott, and consists of a copper medal and a $10,000 prize. Scott entrusted the management of the awards to the Corporation of Philadelphia. Why he chose an American city to administer the award is not known. Today, the Board of Directors of City Trusts confers the honor.
The first John Scott Awards were made in 1834, for the inventions of the knitting machine and a door lock. In this century, most of the awards have been granted to contributors to science and medicine. Famous recipients of the John Scott Award include Mme. Curie, Thomas Edison, the Wright brothers and Jonas Salk.
Dr. Blumberg's achievements have had a far-reaching impact on public health around the globe. He discovered the hepatitis B virus in 1967. Since then, he has provided major insights into the development and prevention of the hepatitis B infection and the fatal liver diseases associated with it.
In 1976, Dr. Blumberg was awarded the Nobel Prize in medicine for his 1967 discovery, and he has received many subsequent honors, including election to the National Academy of Sciences, the American Philosophical Society and the National Inventors Hall of Fame. From 1989 until 1994, he was master of Balliol College at Oxford University for five years. He has been a member of Fox Chase Cancer Center's staff since 1964, and he is presently senior advisor to the Center president and a Distinguished Scientist.
Fox Chase Cancer Center is one of 34 National Cancer Institute-designated comprehensive cancer centers in the nation. Fox Chase activities include basic and clinical research; prevention, detection, and treatment of cancer; and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.